BIOLASE, Inc. (BIOLQ)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Oct 17, 2025, 4:00 PM EDT
BIOLASE Revenue
BIOLASE had revenue of $10.85 million in the quarter ending September 30, 2024, a decrease of -0.65%. This brings the company's revenue in the last twelve months to $46.03 million, down -7.44% year-over-year. In the year 2023, BIOLASE had annual revenue of $49.16 million with 1.45% growth.
Revenue (ttm)
46.03M
Revenue Growth
-7.44%
P/S Ratio
0.00
Revenue / Employee
293.16K
Employees
157
Market Cap
7.32K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 49.16M | 702.00K | 1.45% |
Dec 31, 2022 | 48.46M | 9.27M | 23.67% |
Dec 31, 2021 | 39.19M | 16.41M | 72.03% |
Dec 31, 2020 | 22.78M | -15.02M | -39.73% |
Dec 31, 2019 | 37.80M | -8.36M | -18.10% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.76B |
Veradigm | 588.02M |
Jushi Holdings | 256.36M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Silence Therapeutics | 27.17M |
Nuo Therapeutics | 1.95M |
Northwest Biotherapeutics | 1.09M |